How to Buy Xtant Medical Holdings Stock
Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures.
Xtant Medical Holdings stock last closed at $0.44, down 2.89% from the previous day, and has decreased 27.17% in one year. It has overperformed other stocks in the Medical Devices industry by 0.45 percentage points. Xtant Medical Holdings stock is currently +8.44% from its 52-week low of $0.40, and -54% from its 52-week high of $0.95.
There are currently 140.26M XTNT shares outstanding. The market value of XTNT is $61.29M. In the past 24 hours, 105,000 XTNT shares were traded.
How to Buy Xtant Medical Holdings Stock
Not sure how to invest in Xtant Medical Holdings stock? Here's how.
- Choose where to buy Xtant Medical Holdings stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Xtant Medical Holdings stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your payment method and add your details.
- Research Xtant Medical Holdings stock: The Xtant Medical Holdings ticker symbol is XTNT. Is Xtant Medical Holdings stock a good investment? Should you buy shares of XTNT? How do XTNT's underlying business fundamentals look? Do top analysts think Xtant Medical Holdings is a good buy? Why has XTNT's stock price moved recently? (Hint: Our stock market research website can help you decide if XTNT is a good stock to buy).
- Execute your XTNT trade: Decide if you will purchase XTNT shares at the current market price or use a limit order to purchase XTNT shares at a given price.
- Track your investment in XTNT: Create a watchlist to get live updates on your position in Xtant Medical Holdings stock.
Step 1: Choose where to buy Xtant Medical Holdings stock
You will need a brokerage account to access the NYSEMKT market and buy XTNT shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in XTNT today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have filled out your info on mobile trading apps, you need to deposit funds:
Watch the tutorial below for more details depositing funds into your brokerage account.
Step 4: Research Xtant Medical Holdings stock
After you have selected the best place to buy Xtant Medical Holdings stock, it's crucial to evaluate their stock prior to investing, so you truly understand the risk as well as the upside.
Overview of key XTNT info
XTNT Due Diligence Score
WallStreetZen was designed to help average investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on XTNT's stock page.
Is XTNT stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge XTNT's true value.
Using relative valuations methods:
- XTNT may be overvalued based on its P/E ratio of 21.85x, relative to Medical Devices industry P/E ratio of 20.33x
- XTNT could be undervalued based on its P/B ratio of 1.26x, relative to Medical Devices industry P/B ratio of 2.92x
You can do additional valuation research on XTNT's stock here.
XTNT Financial Health Summary
Positive Health Checks:
- XTNT profit margin has gone up from -9.8% to 1.5% in the past year.
- There are more short-term assets than long-term liabilities on the XTNT balance sheet.
- There are more short-term assets than short-term liabilities on the XTNT balance sheet.
- Total XTNT debt is lower than 5 years ago, relative to shareholder equity.
- XTNT's operating cash flow of $9.15M allows it to safely service it's debt of $15.44M.
Negative Health Checks:
- XTNT has a relatively high debt to equity ratio of 0.61.
- XTNT earnings of $7.13M is not sufficient to cover its interest payments.
Is it a good time to buy Xtant Medical Holdings stock, according to Wall Street analysts?
Out of 1 Equities analysts who give recommendations on XTNT, the consensus analyst rating on XTNT is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Xtant Medical Holdings stock forecast page.
XTNT Trading Indicators
XTNT Growth Metrics
Last year, XTNT revenue was $121.91M. Over the past 5 year, XTNT's revenue has grown by 18.99% per year. This was faster than the Medical Devices industry average of 10.18%.
Dive into XTNT's earnings and revenue performance here.
Who is buying/selling XTNT?
In the last 12 months, executives and large shareholders at XTNT have sold more shares than they have bought.
Mark A. Schallenberger, Chief Operating Officer of XTNT, was the latest XTNT insider to sell. They sold $4,471.22 worth of XTNT shares on Feb 15, 2026.
Research more about who owns XTNT stock here.
Does XTNT stock generate passive income?
No, Xtant Medical Holdings doesn't provide an income stream by paying out dividends.
XTNT Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your XTNT trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want more assistance buying stocks on eToro, click the helpful video below:
Step 6: Track your investment in XTNT
Now that you own some XTNT stock, you'll want to stay up-to-date on your stock purchase.
Add XTNT to a watchlist to keep tabs on your XTNT stock.
XTNT Feed
How to Buy Stock in Xtant Medical Holdings
To reiterate, here are the 6 steps you need to take to buy Xtant Medical Holdings stock right now:
- Choose where to buy Xtant Medical Holdings stock
- Sign up for a brokerage account
- Fund your brokerage account
- Research Xtant Medical Holdings stock
- Execute your XTNT trade
- Track your investment in XTNT
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Xtant Medical Holdings, get started below.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.